Join
Live feed
·
INSIDERFilingvia Quantisnow
ARS Pharmaceuticals Inc. logo

Chief Legal Officer Fitzpatrick Alexander A sold $33,550 worth of shares (3,355 units at $10.00) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 90,910 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SPRY· ARS Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRY (ARS Pharmaceuticals Inc.) and more on Quantisnow.